U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07701876) titled 'Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)' on July 08.
Brief Summary: Heart failure is a serious condition where the heart cannot pump blood effectively. Some patients with severe heart failure (known as heart failure with reduced ejection fraction, or HFrEF) can experience significant improvement in their heart function after receiving guideline-directed medical therapy. This phenomenon is called heart failure with improved ejection fraction (HFimpEF). However, it is not fully understood why some patients improve while others do not.
This study aims to explore the molecular mechanisms behind t...